Autopsy report · NCT02163876
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Cause of deathFunding or business
“Based on a business decision unrelated to any safety concerns.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 7 months before it stopped.
- 31 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- StemCells, Inc.
- Sponsor type
- Industry
- Conditions
- Cervical Spinal Cord Injury; Spine Injury; Cervical Spine Injury
- Interventions
- HuCNS-SC cells
- Participants
- 31
- Sites
- 14
- Countries
- Canada, United States
Trials that died the same way
- Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
“Business decision, not related to safety” - A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
“business decision, not safety reasons.” - Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
“Company/sponsor business decision; not due to or related to any safety concerns” - Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
“Business Decision; No Safety Or Efficacy Concerns. (See below)” - Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
“Company decision (not a safety issue)”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.